V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330007745 | 330004570 | 1.73 | 46.3 | Curative (C) | 2018-03-02 | 2018-03-02 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330012539 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330007746 | 330008495 | 1.59 | 96 | Curative (C) | 2013-01-05 | 2013-10-22 | ALL UKALL2011 Maintenance A1 | N | N | 330012542 | UKALL2011 |
| 330007747 | 330004574 | 1.53 | 76.4 | Curative (C) | 2014-02-08 | 2014-03-19 | CARBOPLATIN + RT | 2 | null | 330012543 | CARBOPLATIN + RT |
| 330007748 | 330004574 | null | 82.2 | Neo-adjuvant (N) | 2016-03-04 | 2016-03-05 | ALL UKALL2011 Aug BFM Cons C PegAsp | 2 | null | 330012543 | UKALL2011 |
| 330007749 | 330004575 | 1.69 | 55.7 | Palliative (P) | 2014-06-24 | 2014-07-12 | Paclitaxel 7 day | N | N | 330012547 | PACLITAXEL |
| 330007750 | 330004576 | 1.76 | 89.5 | Neo-adjuvant (N) | 2015-06-18 | 2015-06-18 | EURAMOS TRIAL | N | N | 330012550 | EURAMOS TRIAL |
| 330007752 | 330004578 | 1.8 | 43.8 | Neo-adjuvant (N) | null | 2017-12-14 | EURAMOS TRIAL | 02 | N | 330012554 | EURAMOS TRIAL |
| 330007753 | 330004579 | 1.83 | 74.9 | Palliative (P) | 2017-11-12 | 2017-12-22 | Cetuximab + Radiotherapy Maint | N | N | 330012557 | CETUXIMAB + RT |
| 330007754 | 330004580 | 0 | 83.5 | Palliative (P) | 2015-09-18 | 2015-10-25 | BENDAMUSTINE + RITUXIMAB | 2 | null | 330012562 | BENDAMUSTINE + RITUXIMAB |
| 330007755 | 330004582 | null | null | Palliative (P) | null | 2016-03-06 | Paclitaxel (2 or 3 weekly) | null | null | 330012563 | PACLITAXEL |
| 330007756 | 330004583 | 1.84 | null | Curative (C) | 2015-05-28 | 2015-07-24 | EURAMOS TRIAL | N | N | 330012564 | EURAMOS TRIAL |
| 330007757 | 330004584 | null | null | Palliative (P) | 2014-02-04 | 2014-02-14 | CARBOPLATIN + PACLITAXEL | N | N | 330012571 | CARBOPLATIN + PACLITAXEL |
| 330007758 | 330004585 | 1.74 | 123.2 | Palliative (P) | 2014-09-02 | 2014-09-05 | Carboplatin + Paclitaxel (3 weekly) | N | N | 330012576 | CARBOPLATIN + PACLITAXEL |
| 330007759 | 330004586 | 1.8 | 73.65 | Neo-adjuvant (N) | 2016-09-16 | 2016-10-14 | CARBOPLATIN + ETOPOSIDE | N | Y | 330012577 | CARBOPLATIN + ETOPOSIDE |
| 330007760 | 330004586 | 1.8 | null | Curative (C) | 2017-05-18 | 2017-05-21 | VAI (Ifos 3g/m2) | 02 | Y | 330012577 | VAI |
| 330007761 | 330004587 | 1.59 | 72 | Curative (C) | null | 2017-05-27 | VAI (Ifos 3g/m2) | N | N | 330012594 | VAI |
| 330007762 | 330004588 | 1.75 | 79 | Neo-adjuvant (N) | 2017-10-03 | 2017-10-04 | Cetuximab + Radiotherapy Maint | 02 | N | 330012594 | CETUXIMAB + RT |
| 330007763 | 330004588 | 1.02 | 61 | Curative (C) | 2017-04-11 | 2017-04-29 | Bendamustine+Rituximab (1st Course) | null | null | 330012594 | BENDAMUSTINE + RITUXIMAB |
| 330007764 | 330004589 | null | 89.7 | Neo-adjuvant (N) | 2013-12-19 | 2014-01-28 | Cisplatin + Docetaxel +Fluorouracil | 2 | null | 330012604 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330007765 | 330004591 | null | 54.55 | Palliative (P) | 2013-06-07 | 2013-06-17 | Carboplatin + Etoposide IV 3 day | null | null | 330012606 | CARBOPLATIN + ETOPOSIDE |
| 330007766 | 330004591 | 1.6 | 46.8 | Palliative (P) | null | 2017-12-15 | CARBOPLATIN + PACLITAXEL | 2 | null | 330012606 | CARBOPLATIN + PACLITAXEL |
| 330007768 | 330004592 | 1.79 | 90 | Curative (C) | 2014-07-11 | 2014-07-11 | VAI (Ifos 3g/m2) | N | N | 330012613 | VAI |
| 330007769 | 330004593 | 1.57 | 22.3 | Palliative (P) | 2015-01-15 | 2015-03-24 | ALL UKALL2011 (ProtM-A) C PegAsp | N | Y | 330012615 | UKALL2011 |
| 330007770 | 330004595 | 1.76 | 97.7 | Palliative (P) | 2016-06-15 | 2016-09-12 | Paclitaxel 7 day | N | N | 330012615 | PACLITAXEL |
| 330007771 | 330004595 | 1.53 | 70.1 | Palliative (P) | 2015-10-08 | 2015-11-03 | Paclitaxel 7 day | N | N | 330012615 | PACLITAXEL |
| 330007772 | 330004596 | 1.75 | null | null | 2016-12-11 | 2016-12-14 | VAI (Ifos 3g/m2) | 02 | N | 330012618 | VAI |
| 330007773 | 330004598 | null | 57.2 | Disease modification (D) | 2016-01-26 | 2016-01-29 | BENDAMUSTINE + RITUXIMAB | 2 | null | 330012628 | BENDAMUSTINE + RITUXIMAB |
| 330007774 | 330004599 | 1.78 | 95.8 | Disease modification (D) | 2014-09-22 | 2014-10-17 | BENDAMUSTINE + RITUXIMAB | N | Y | 330012629 | BENDAMUSTINE + RITUXIMAB |
| 330007775 | 330004599 | 0 | 67.4 | Palliative (P) | 2018-07-01 | 2018-07-10 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 330012629 | CARBO + FLUOROURACIL |
| 330007776 | 330004602 | 0 | null | null | 2016-12-27 | 2017-04-22 | Carboplatin + Etoposide IV 3 day | N | N | 330012638 | CARBOPLATIN + ETOPOSIDE |
| 330007777 | 330004602 | 1.72 | 96.5 | Palliative (P) | 2014-07-23 | 2014-07-27 | Carboplatin + Etoposide IV 3 day | N | N | 330012638 | CARBOPLATIN + ETOPOSIDE |
| 330007778 | 330004604 | 1.71 | 52.3 | Curative (C) | 2016-12-16 | 2016-12-16 | CARBOPLATIN + RT | N | N | 330012642 | CARBOPLATIN + RT |
| 330007781 | 330004611 | 1.73 | null | Palliative (P) | 2016-08-31 | 2016-10-19 | Carboplatin + Etoposide iv&po | N | N | 330012654 | CARBOPLATIN + ETOPOSIDE |
| 330007782 | 330004612 | 1.73 | 67.7 | Adjuvant (A) | 2015-10-02 | 2015-10-05 | Cetuximab + Radiotherapy Maint | N | N | 330012662 | CETUXIMAB + RT |
| 330007783 | 330008513 | 0 | 22 | Adjuvant (A) | null | 2015-06-03 | Carboplatin + Etoposide iv&po | null | null | 330012663 | CARBOPLATIN + ETOPOSIDE |
| 330007784 | 330004613 | null | 38.4 | Curative (C) | 2017-08-18 | 2017-08-18 | EURAMOS TRIAL | N | N | 330012664 | EURAMOS TRIAL |
| 330007785 | 330008514 | 1.59 | 45 | Palliative (P) | 2017-06-14 | 2017-11-28 | Carboplatin + Paclitaxel (3 weekly) | 02 | Y | 330012673 | CARBOPLATIN + PACLITAXEL |
| 330007786 | 330004615 | null | 77 | Palliative (P) | 2015-01-26 | 2015-02-21 | Paclitaxel (2 or 3 weekly) | null | Y | 330012677 | PACLITAXEL |
| 330007787 | 330004617 | 1.69 | 70.9 | Curative (C) | 2015-06-11 | 2015-06-25 | Carboplatin + Etoposide IV 3 day | 02 | N | 330012680 | CARBOPLATIN + ETOPOSIDE |
| 330007788 | 330004617 | null | 11.3 | Palliative (P) | 2014-04-09 | 2014-04-10 | ALL UKALL2011 Cap Int Maint C PAsp | Y | null | 330012680 | UKALL2011 |
| 330007789 | 330004617 | 1.75 | 43.8 | Palliative (P) | 2014-12-20 | 2015-02-07 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 330012680 | CARBO + FLUOROURACIL |
| 330007790 | 330004618 | 1.54 | null | Curative (C) | 2015-10-14 | 2015-10-22 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 330012690 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330007791 | 330008516 | 1.63 | 63 | Curative (C) | 2015-08-07 | 2015-08-07 | BENDAMUSTINE + RITUXIMAB | N | N | 330012690 | BENDAMUSTINE + RITUXIMAB |
| 330007792 | 330004619 | null | null | Palliative (P) | 2014-05-05 | 2014-10-14 | Carboplatin + Etoposide iv&po | 2 | null | 330012705 | CARBOPLATIN + ETOPOSIDE |
| 330007793 | 330004620 | 0 | 73 | Palliative (P) | 2016-08-30 | 2016-09-02 | BENDAMUSTINE + RITUXIMAB | N | N | 330012707 | BENDAMUSTINE + RITUXIMAB |
| 330007794 | 330008517 | 1.68 | 67.4 | Adjuvant (A) | null | 2014-09-30 | Cetuximab + Radiotherapy Maint | N | null | 330012707 | CETUXIMAB + RT |
| 330007795 | 330004621 | 1.75 | 79 | Palliative (P) | 2013-03-05 | 2013-11-30 | ALL UKALL2011 Maintenance A1 | N | N | 330012713 | UKALL2011 |
| 330007796 | 330004623 | 2 | 12 | Curative (C) | 2014-06-15 | 2014-08-04 | EURAMOS TRIAL | 2 | N | 330012718 | EURAMOS TRIAL |
| 330007797 | 330004624 | 0 | 121.2 | Curative (C) | 2013-05-21 | 2013-05-21 | Cetuximab + Radiotherapy Maint | N | N | 330012718 | CETUXIMAB + RT |
| 330007798 | 330004624 | 1.72 | null | Palliative (P) | 2017-08-08 | 2017-09-30 | ALL UKALL2011 Del Int A Pt1 (PAsp) | 02 | N | 330012718 | UKALL2011 |